Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Enhanced detection of circulating tumor DNA by fragment size analysis.

Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Østrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sørensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N.

Sci Transl Med. 2018 Nov 7;10(466). pii: eaat4921. doi: 10.1126/scitranslmed.aat4921.

PMID:
30404863
2.

Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.

Thomas JSJ, Provenzano E, Hiller L, Dunn J, Blenkinsop C, Grybowicz L, Vallier AL, Gounaris I, Abraham J, Hughes-Davies L, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Caldas C, Bartlett JM, Cameron DA, Hayward RL, Earl HM.

Mod Pathol. 2017 Aug;30(8):1069-1077. doi: 10.1038/modpathol.2017.30. Epub 2017 May 26.

3.

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.

Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Gounaris I, Abraham JE, Hughes-Davies L, McAdam K, Chan S, Ahmad R, Hickish T, Rea D, Caldas C, Bartlett JMS, Cameron DA, Provenzano E, Thomas J, Hayward RL; ARTemis Investigators Group.

Ann Oncol. 2017 Aug 1;28(8):1817-1824. doi: 10.1093/annonc/mdx173.

4.

Comment on the FOWARC Study Report.

Gounaris I.

J Clin Oncol. 2017 May 1;35(13):1494. doi: 10.1200/JCO.2016.70.5988. Epub 2017 Jan 23. No abstract available.

PMID:
28113033
5.

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

Parkinson CA, Gale D, Piskorz AM, Biggs H, Hodgkin C, Addley H, Freeman S, Moyle P, Sala E, Sayal K, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, Rosenfeld N, Brenton JD.

PLoS Med. 2016 Dec 20;13(12):e1002198. doi: 10.1371/journal.pmed.1002198. eCollection 2016 Dec.

6.

Trastuzumab-associated cardiac events in the Persephone trial.

Earl HM, Vallier AL, Dunn J, Loi S, Ogburn E, McAdam K, Hughes-Davies L, Harnett A, Abraham J, Wardley A, Cameron DA, Miles D, Gounaris I, Plummer C, Hiller L.

Br J Cancer. 2016 Dec 6;115(12):1462-1470. doi: 10.1038/bjc.2016.357. Epub 2016 Nov 22.

7.

Lesson of the month 2: Cauda equina in Cushing's syndrome.

Maslin D, Gounaris I, Ng K, Corrie P.

Clin Med (Lond). 2016 Feb;16(1):88-90. doi: 10.7861/clinmedicine.16-1-88.

PMID:
26833526
8.

Survival of patients with metastatic breast cancer with or without locoregional therapy.

Gounaris I.

Lancet Oncol. 2015 Dec;16(16):e585. doi: 10.1016/S1470-2045(15)00367-8. No abstract available.

PMID:
26678205
9.

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

Gounaris I, Iddawela M, Parkinson C, Pratt J, Hatcher H, Basu B, Tan LT, Brenton JD, Earl HM.

Anticancer Drugs. 2016 Mar;27(3):239-44. doi: 10.1097/CAD.0000000000000320.

PMID:
26575000
10.

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

Earl H, Provenzano E, Abraham J, Dunn J, Vallier AL, Gounaris I, Hiller L.

BMC Med. 2015 Sep 22;13:234. doi: 10.1186/s12916-015-0472-7.

11.

Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.

Ford H, Gounaris I.

Therap Adv Gastroenterol. 2015 Jul;8(4):189-205. doi: 10.1177/1756283X15585468. Review.

12.

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Abraham J, Thomas J, Provenzano E, Hughes-Davies L, Gounaris I, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Bartlett J, Caldas C, Cameron DA, Hayward L; ARTemis Investigators.

Lancet Oncol. 2015 Jun;16(6):656-66. doi: 10.1016/S1470-2045(15)70137-3. Epub 2015 May 11.

13.

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Sayal K, Gounaris I, Basu B, Freeman S, Moyle P, Hosking K, Iddawela M, Jimenez-Linan M, Abraham J, Brenton J, Hatcher H, Earl H, Parkinson C.

Int J Gynecol Cancer. 2015 Jul;25(6):977-84. doi: 10.1097/IGC.0000000000000448.

14.

Molecular pathogenesis of ovarian clear cell carcinoma.

Gounaris I, Brenton JD.

Future Oncol. 2015;11(9):1389-405. doi: 10.2217/fon.15.45. Review.

PMID:
25952785
15.

Application of ARID1A to murine formalin-fixed paraffin embedded tissue using immunohistochemistry.

Howat W, Miller J, Gounaris I.

Version 2. F1000Res. 2014 Oct 15 [revised 2015 Jan 1];3:244. doi: 10.12688/f1000research.5514.2. eCollection 2014.

16.

Presentation and management of pulmonary artery sarcoma.

Wong HH, Gounaris I, McCormack A, Berman M, Davidson D, Horan G, Pepke-Zaba J, Jenkins D, Earl HM, Hatcher HM.

Clin Sarcoma Res. 2015 Jan 21;5(1):3. doi: 10.1186/s13569-014-0019-2. eCollection 2015.

17.

Pulmomary embolism in Bradford, UK: role of end-tidal CO2 as a screening tool.

Gounaris I.

Clin Med (Lond). 2014 Aug;14(4):455. doi: 10.7861/clinmedicine.14-4-455a. No abstract available.

PMID:
25099860
18.

Trabectedin for advanced soft tissue sarcomas: a single institution experience.

Gounaris I, Hatcher HM, Davidson D, Sherbourne K, Alam S, Zaki KA, Horan G, Earl HM.

Future Oncol. 2014 Aug;10(11):1843-51. doi: 10.2217/fon.14.10. Epub 2014 Jan 22.

19.

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.

Earl HM, Vallier AL, Hiller L, Fenwick N, Young J, Iddawela M, Abraham J, Hughes-Davies L, Gounaris I, McAdam K, Houston S, Hickish T, Skene A, Chan S, Dean S, Ritchie D, Laing R, Harries M, Gallagher C, Wishart G, Dunn J, Provenzano E, Caldas C; Neo-tAnGo Investigators.

Lancet Oncol. 2014 Feb;15(2):201-12. doi: 10.1016/S1470-2045(13)70554-0. Epub 2013 Dec 19.

20.

Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?

Gounaris I, Charnock-Jones DS, Brenton JD.

J Pathol. 2011 Oct;225(2):157-60. doi: 10.1002/path.2970.

PMID:
21898874
21.

Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients.

Gounaris I, Provenzano E, Vallier AL, Hiller L, Iddawela M, Hilborne S, Taylor K, Britton P, Earl HM, Sinnatamby R.

Breast Cancer Res Treat. 2011 Jun;127(2):459-69. doi: 10.1007/s10549-011-1454-x. Epub 2011 Mar 25.

PMID:
21437610
22.

Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.

Gounaris I, Zaki K, Corrie P.

JOP. 2010 Mar 5;11(2):113-23. Review.

23.

Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.

Gounaris I, Ahmad A.

J Oncol Pharm Pract. 2010 Dec;16(4):277-9. doi: 10.1177/1078155209349201. Epub 2009 Oct 15.

PMID:
19833683
24.

Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.

Gounaris I, Rahamim J, Shivasankar S, Earl S, Lyons B, Yiannakis D.

Anticancer Drugs. 2007 Nov;18(10):1227-30.

PMID:
17893525
25.

Five-gene signature in non-small-cell lung cancer.

Gounaris I.

N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583. No abstract available.

PMID:
17436431
26.

Trastuzumab in breast cancer.

Gounaris IG.

N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4. No abstract available.

PMID:
16470950
27.

Changes of plasma fibrinogen and fibrinolysis in response to competition stress in swimming coaches.

Loupos D, Tsalis G, Alexiou S, Gounaris I.

J Sports Med Phys Fitness. 2005 Sep;45(3):424-7.

PMID:
16230996
28.

Restriction site and genetic map of Cucurbita pepo chloroplast DNA.

Lim H, Gounaris I, Hardison RC, Boyer CD.

Curr Genet. 1990 Oct;18(3):273-5.

PMID:
2249258
29.

Chromoplast-Specific Proteins in Capsicum annuum.

Hadjeb N, Gounaris I, Price CA.

Plant Physiol. 1988 Sep;88(1):42-5.

30.

[CONSIDERATIONS ON PROBLEMS OF PROTECTION AGAINST X-RAYS DURING RADIOSCOPY AND RADIOGRAPHY].

GOUNARIS IG.

J Radiol Electrol Med Nucl. 1963 Nov;44:735-8. French. No abstract available.

PMID:
14094224
31.

[Studies on topography of cardiac orifices and on their relationship; contrast radiography of the coronary vessels].

APOSTOLOKIS G, GOUNARIS IG.

J Radiol Electrol Arch Electr Medicale. 1953;34(7-8):516-8. Undetermined Language. No abstract available.

PMID:
13131286
32.

[Radiotherapy of scapulohumeral periarthritis].

GOUNARIS IG.

J Radiol Electrol Arch Electr Medicale. 1950;31(5-6):324. Undetermined Language. No abstract available.

PMID:
15437489
33.

[Effect of roentgen irradiation on the reticuloendothelial system; experimental research].

GOUNARIS IG.

J Radiol Electrol Arch Electr Medicale. 1950;31(5-6):324. Undetermined Language. No abstract available.

PMID:
15437488
34.

[Anatomo-radiologic study of the heart].

GOUNARIS IG.

J Radiol Electrol Arch Electr Medicale. 1950;31(5-6):323. Undetermined Language. No abstract available.

PMID:
15437487

Supplemental Content

Loading ...
Support Center